Ferumoxytol
Ferumoxytol is a pharmaceutical drug with 61 clinical trials. Currently 9 active trials ongoing. Historical success rate of 73.8%.
Success Metrics
Based on 31 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
12
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
63.3%
31 of 49 finished
36.7%
18 ended early
9
trials recruiting
61
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
Clinical Trials (61)
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
Early Antenatal Support for Iron Deficiency Anemia
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation
Calculating Wall Shear Stress in Infant Pulmonary Veins
DCE MRI in Patients With Pancreatic Cancer
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation
IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 61